Pillar Pharmaceuticals I LP 13D and 13G filings for Idera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-08-17 4:30 pm Purchase | 2020-07-13 | 13D | Idera Pharmaceuticals, Inc. IDRA | Pillar Pharmaceuticals I LP | 1,743,774 19.900% | 1,007,996 (+137.00%) | Filing |